Cancer BiologybioRxivPreprint
Functional drug susceptibility testing based on biophysical measurements predicts patient outcome in glioblastoma patient-derived neurosphere models
M. A. Stockslager, S. Malinowski, M. Touat…·S. R. Manalis
Using biophysical assays on glioblastoma patient-derived neurosphere models, the study finds that ex vivo drug susceptibility testing predicts patient survival with similar accuracy to MGMT promoter methylation.
DOI 10.1101/2020.08.05.238154